BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 907408)

  • 1. Comparison of the cardiac effects of ASI-222 HCl, an aminosugar cardiac glycoside, and digoxin.
    Cook LS; Caldwell RW; Nash CB
    Arch Int Pharmacodyn Ther; 1977 Jun; 227(2):220-32. PubMed ID: 907408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of aminosugar cardiac glycosides with ouabain and digoxin on Na+, K+ -adenosine triphosphatase and cardiac contractile force.
    Caldwell RW; Nash CB
    J Pharmacol Exp Ther; 1978 Jan; 204(1):141-8. PubMed ID: 145490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological studies of a new 4-aminosugar cardiac glycoside (ASI-222).
    Caldwell RW; Nash CB
    J Pharmacol Exp Ther; 1976 Apr; 197(1):19-26. PubMed ID: 1263129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenergic and cholinergic mechanisms in digitalis inotropy.
    Cook LS; Caldwell RW; Nash CB; Doherty JE; Straub KD
    J Pharmacol Exp Ther; 1982 Dec; 223(3):761-5. PubMed ID: 7143238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and cardiac actions of a polar aminocardenolide and digoxin in the conscious dog.
    Songu-Mize E; Nash CB; Elam JT; Caldwell RW
    J Pharmacol Exp Ther; 1983 Jul; 226(1):65-70. PubMed ID: 6864551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of an aminosugar cardiac glycoside, ASI-222 HCl, in the heart-lung preparation of the dog.
    Cook LS; Caldwell RW; Nash CB
    J Cardiovasc Pharmacol; 1979; 1(5):551-9. PubMed ID: 94411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inotropic and toxic effects of a polar cardiac glycoside derivative in the dog.
    Mudge GH; Lloyd BL; Greenblatt DJ; Smith TW
    Circ Res; 1978 Dec; 43(6):847-54. PubMed ID: 709746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cardiac beta-adrenergic blockade or denervation on cardiotoxicity of digoxin and an aminosugar cardenolide.
    Puryear SK; Nash CB; Caldwell RW
    J Cardiovasc Pharmacol; 1981; 3(1):113-27. PubMed ID: 6160341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different patterns of autonomic nerve activity produced by a polar vs. a neutral cardiac glycoside.
    Rebagay WR; Caldwell RW
    J Pharmacol Exp Ther; 1990 Apr; 253(1):180-4. PubMed ID: 2329504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of an aminocardenolide and digoxin upon atrioventricular refractory period in the dog.
    Caldwell RW; Nash CB
    J Pharmacol Exp Ther; 1985 Dec; 235(3):583-8. PubMed ID: 4078725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of transient vagal cold blockade upon reflex actions of a polar and nonpolar cardiac glycoside.
    Caldwell RW; Rebagay WR
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1022-7. PubMed ID: 1527711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of the toxic to inotropic dose ratio of digoxin by excluding central nervous system influences on the heart.
    Pace DG; Gillis RA
    Arch Int Pharmacodyn Ther; 1982 Jan; 255(1):103-16. PubMed ID: 7073395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inotropic activity of digitoxigenin glucoside and related glycosides.
    Altman PM; Einstein R; Goodman AH; Thomas RE
    Arzneimittelforschung; 1988 Aug; 38(8):1115-9. PubMed ID: 3196405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological investigation on asclepin--a new cardenolide from Asclepias curassavica. Part II. Comparative studies on the inotropic and toxic effects of asclepin, g-strophantin, digoxin and digitoxin).
    Patnaik GK; Köhler E
    Arzneimittelforschung; 1978; 28(8):1368-72. PubMed ID: 380581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in cardiac glycoside activity produced by aminosugar addition.
    Cook LS; Caldwell RW; Nash CB
    J Pharmacol Exp Ther; 1980 Oct; 215(1):198-204. PubMed ID: 7452483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative ability of digoxin and an aminosugar cardiac glycoside to bind to and inhibit Na+,K+-adenosine triphosphatase. Effect of potassium.
    Songu-Mize E; Gunter JL; Caldwell RW
    Biochem Pharmacol; 1989 Nov; 38(21):3689-95. PubMed ID: 2557026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of halothane, sevoflurane and desflurane on the force-frequency relation in the dog heart in vivo.
    Preckel B; Obal D; Müllenheim J; Hennes J; Heiderhoff M; Thämer V; Schlack W
    Can J Anaesth; 2006 Nov; 53(11):1118-25. PubMed ID: 17079640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of L-dopa on myocardial contractile force: a reappraisal.
    Wenger JJ; Osborne MW
    Arch Int Pharmacodyn Ther; 1975 Oct; 217(2):251-6. PubMed ID: 1190920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of calcium antagonist, 6-(N, N-diethylamino) hexyl-3, 4, 5-trimethoxybenzoate, on digitalis-induced arrhythmias and cardiac contractions.
    Chiou CY; Malagodi MH; Sastry BV; Posner P
    J Pharmacol Exp Ther; 1976 Aug; 198(2):444-9. PubMed ID: 948035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.